Roche to Launch CVRM Hub in Boston

Roche has announced the launch of an innovation center in Boston that will serve as its cardiovascular, renal, and metabolism (CVRM) research and development hub.

The Roche Genentech Innovation Center Boston will also support efforts in artificial intelligence and data science to accelerate drug discovery and development. The center, which may employ up to 500 people, will be led by Manu Chakravarthy, senior vice president and global head of CVRM product development.

The center will be located at Harvard University’s Enterprise Research Campus, a mixed-use development comprising research and laboratory space, residential buildings, a hotel, conference center, retail units, and a variety of community-centered outdoor spaces. The first phase of construction should be completed in 2026.

Source: Press release